Splendo strongly believes in collaboration to improve quality and increase innovation and output. We collaborate with academic, medical industry, and tech industry partners to build products and services that make a difference.
Set up for success
SplendoHealth is part of the Duke startup program. A program that has helped 179 companies grow and raise over $5.7 billion in public and private funding.
Splendo is consortium partner for a Horizon2020 grant project for portable platform for the assessment of microvascular health in COVID-19 patients at the intensive care using data processing with AI analysis.
Splendo is consortium lead for a Eurostars grant project for early detection of heart disease and failure through AI analysis of high resolution data from multiple sensors.